Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
07/06/2000 | CA2356986A1 Compounds and methods for modulation of estrogen receptors |
07/06/2000 | CA2356692A1 Hydrophilic ampholytic polymer |
07/06/2000 | CA2356671A1 Protease inhibitors |
07/06/2000 | CA2356622A1 Compounds which affect mrna stability and uses therefor |
07/06/2000 | CA2356548A1 Human brainiac-5 |
07/06/2000 | CA2356319A1 Thyroid receptor ligands |
07/06/2000 | CA2356098A1 Use of unsaponifiable matters of vegetable oils for preparing a medicine |
07/06/2000 | CA2352896A1 Pyrimidine compounds |
07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
07/05/2000 | EP1015464A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE |
07/05/2000 | EP1015438A1 Protease inhibitors |
07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
07/05/2000 | EP1015423A1 1,3-dihydroxy-20,20-dialkyl-vitamin d 3? analogs |
07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
07/05/2000 | EP1015032A2 High viscosity liquid controlled delivery system as a device |
07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
07/05/2000 | CN1259137A Estra-5(10), 7-dienes with estrogenic activity |
07/05/2000 | CN1259120A Calcilytic compounds |
07/05/2000 | CN1258540A Fracture treating medicine and its preparation |
07/05/2000 | CN1258531A Wind evil-dispelling, meridian passage-dredging and pus-drawing out medicine powder |
07/05/2000 | CN1258515A Medicine powder for treating bone Bi-syndrome and its preparation |
07/05/2000 | CN1258514A Blood stasis removing analgesic plaster and its preparation |
07/05/2000 | CN1054071C Medicinal liquid for injury and its preparation |
07/05/2000 | CN1054056C Preparation of Chinese herb medicine for treating cervical vertebra syndrome |
07/05/2000 | CN1054052C Comedo-elimination preparation |
07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
07/04/2000 | US6083996 Topical compositions for NSAI drug delivery |
07/04/2000 | US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors |
07/04/2000 | US6083956 Optically pure androgen mediator |
07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
07/04/2000 | US6083938 Pyridinylbisphosphonates for use as a therapeutical agent |
07/04/2000 | US6083936 Treatment of estrogen-dependent disorders such as estrogen-dependent cancers; also useful in diagnostic techniques such as magnetic resonance imaging and magnetic resonance spectroscopy |
07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
07/04/2000 | US6083906 Method of regulating nitric oxide production or arthritis with soluble IL-17 receptor |
07/04/2000 | US6083903 Boronic ester and acid compounds, synthesis and uses |
07/04/2000 | US6083536 Super-critical lipid extract from mussels having anti-inflammatory activity |
07/04/2000 | US6083521 Drugs and polyethylene carbonates |
07/04/2000 | CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone |
06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
06/29/2000 | WO2000037620A1 Crystalline form of activated trap and use thereof for structure-based drug design |
06/29/2000 | WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof |
06/29/2000 | WO2000037487A1 αvβ6 INTEGRIN INHIBITORS |
06/29/2000 | WO2000037472A2 Substituted pirroloindoles |
06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
06/29/2000 | WO2000037436A1 Sulfonamide hydroxamates |
06/29/2000 | WO2000037433A1 Inhibitors of matrix metalloproteinases |
06/29/2000 | WO2000037358A1 NOVEL sPLA2 INHIBITORS |
06/29/2000 | WO2000037124A1 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
06/29/2000 | WO2000037094A2 Therapeutic applications of flint polypeptides |
06/29/2000 | WO2000037093A1 Bone resorption inhibitors |
06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
06/29/2000 | WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
06/29/2000 | WO2000037053A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
06/29/2000 | WO2000037027A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
06/29/2000 | WO2000037025A2 Antibodies to truncated vegf-d and uses thereof |
06/29/2000 | WO2000012497A3 Quinazoline derivatives as medicaments |
06/29/2000 | WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues |
06/29/2000 | CA2358508A1 Therapeutic applications of flint polypeptides |
06/29/2000 | CA2356765A1 Bone resorption inhibitors |
06/29/2000 | CA2356736A1 Use of etherlysophospholipids as antiinflammatory agents |
06/29/2000 | CA2356366A1 Oil-in-water emulsion comprising a micronised biologically active agent and an appropriate emulsifier system |
06/29/2000 | CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
06/29/2000 | CA2356162A1 Substituted tricyclics |
06/29/2000 | CA2356159A1 Novel spla2 inhibitors |
06/29/2000 | CA2355902A1 Sulfonamide hydroxamates |
06/29/2000 | CA2355896A1 Antibodies to truncated vegf-d and uses thereof |
06/29/2000 | CA2355874A1 .alpha.v.beta.6 integrin inhibitors |
06/29/2000 | CA2355830A1 Crystalline form of activated trap and use thereof for structure-based drug design |
06/29/2000 | CA2355137A1 Non-peptide nk1 receptors antagonists |
06/29/2000 | CA2355074A1 Lymphocytic membrane proteins |
06/29/2000 | CA2354135A1 Group b streptococcus proteins, and their use |
06/29/2000 | CA2353848A1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
06/28/2000 | EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
06/28/2000 | EP1012302A1 Human nucleotide pyrophosphohydrolase |
06/28/2000 | EP1012278A1 Murine and human cerberus-like proteins and compositions comprising them |
06/28/2000 | EP1012273A2 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012242A1 Human sigma receptor |
06/28/2000 | EP1012177A1 Estrogen receptor |
06/28/2000 | EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity |
06/28/2000 | EP1012137A1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists |
06/28/2000 | EP1012136A1 Aromatic c 16?-c 20?-substituted tetrahydro prostaglandins useful as fp agonists |
06/28/2000 | EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
06/28/2000 | EP1011709A1 Inhibition of apoptotis using prosaposin receptor agonists |
06/28/2000 | EP1011690A1 Cross-linked polysaccharide drug carrier |
06/28/2000 | EP1011670A1 Method for treatment of non-rheumatoid athritis |
06/28/2000 | EP1011663A1 BETA-LACTAM INHIBITORS OF CoA-IT |
06/28/2000 | EP0639224B1 Lectin domain variants of selectin |
06/28/2000 | EP0557418B1 A beta-type transforming growth factor |
06/28/2000 | CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels |
06/28/2000 | CN1257733A Medical capsule for treating rheumatoid arthritis |
06/28/2000 | CN1257727A Chinese-medicinal pills for treating ischemic necrosis of femur head |
06/28/2000 | CN1257725A Chinese medicine for treating bone fracture |
06/28/2000 | CN1257715A Tincture for treating rheumatoid arthritis and its preparing process |
06/28/2000 | CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them |